Template:Bleeding: Difference between revisions

	Bleeding Microchapters
Home
Patient Information
Overview
Classification
Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria
Causes
Treatment
Emergency Bleeding Control
Reversal of Anticoagulation and Antiplatelet in Active Bleed
Perioperative Bleeding
Coagulation Monitoring
Anemia Management
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric Surgery
Congenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding Disorders
Bleeding On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bleeding All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bleeding
CDC on Bleeding
Bleeding in the news
Blogs on Bleeding
Directions to Hospitals Treating Bleeding
Risk calculators and risk factors for Bleeding

@@ Line 112: / Line 112: @@
 !
 : [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]]
 |-
 !

Revision as of 14:23, 24 April 2014